Advertisement

Increasing problems in the therapy of enterococcal infections

  • G. M. Eliopoulos
Editorial

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Moellering RC The enterococci: an enigma and a continuing therapeutic challenge. European Journal of Clinical Microbiology & Infectious Diseases 1990, 9: 73–74.Google Scholar
  2. 2.
    Shlaes DM, Binczewski B Enterococcal resistance to vancomycin and related cyclic glycopeptide antibiotics. European Journal of Clinical Microbiology & Infectious Diseases 1990, 9: 106–110.Google Scholar
  3. 3.
    Horodniceanu T, Bougueleret L, El-Solh N, Bieth G, Delbos F High-level, plasmid borne resistance to gentamicin inStreptococcus faecalis subspecieszymogenes. Antimicrobial Agents and Chemotherapy 1979, 16: 686–689.PubMedGoogle Scholar
  4. 4.
    Hodel-Christian SL, Murray BE Characterization of the gentamicin resistance transposon Tn5281 fromEnterococcus faecalis and comparison to staphylococcal transposons, Tn4001 and Tn4031. Antimicrobial Agents and Chemotherapy 1991, 35: 1147–1152.PubMedGoogle Scholar
  5. 5.
    Murray BE The life and times of the enterococcus. Clinical Microbiology Reviews 1990, 3: 46–65.PubMedGoogle Scholar
  6. 6.
    Eliopoulos GM, Wennersten CB, Zighelboim-Daum S, Reiszner E, Goldmann D, Moellering RC High-level resistance to gentamicin in clinical isolates ofStreptococcus (Enterococcus) faecium. Antimicrobial Agents and Chemotherapy 1988, 32: 1528–1532.PubMedGoogle Scholar
  7. 7.
    Grayson ML, Eliopoulos GM, Wennersten CB, Ruoff KL, DeGirolami PC, Ferraro MJ, Moellering RC Increasing resistance to β-lactam antibiotics among clinical isolates ofEnterococcus faecium: a 22-year review at one institution. Antimicrobial Agents and Chemotherapy 1991, 35: 2180–2184.PubMedGoogle Scholar
  8. 8.
    Eliopoulos GM, Eliopoulos CT Therapy of enterococcal infections. European Journal of Clinical Microbiology & Infectious Diseases 1990, 9: 118–126.Google Scholar
  9. 9.
    Bush LM, Calmon I, Cherney CL, Wendeler M, Pitsakis P, Poupard J, Levison ME, Johnson CC High-level penicillin resistance among isolates of enterococci. Implications for treatment of enterococcal infections. Annals of Internal Medicine 1989, 110: 515–520.PubMedGoogle Scholar
  10. 10.
    Grayson ML, Eliopoulos GM, Wennersten CB, Ruoff KL, Klimm K, Sapico FL, Bayer AS, Moellering RC Comparison ofEnterococcus raffinosus withEnterococcus avium on the basis of penicillin susceptibility, penicillin-binding protein analysis, and high-level aminoglycoside resistance. Antimicrobial Agents and Chemotherapy 1991, 35: 1408–1412.PubMedGoogle Scholar
  11. 11.
    Cercenado E, García-Leoni ME, Rodeño P, Rodríguez-Créixems M Ampicillin-resistant enterococci. Journal of Clinical Microbiology 1990, 28: 829.PubMedGoogle Scholar
  12. 12.
    Rhinehart E, Smith NE, Wennersten C, Gorss E, Freeman J, Eliopoulos GM, Moellering RC, Goldmann DA Rapid dissemination of β-lactamase-producing aminoglycoside-resistantEnterococcus faecalis among patients and staff on an infant-toddler surgical ward. New England Journal of Medicine 1990, 323: 1814–1818.PubMedGoogle Scholar
  13. 13.
    Wells VD, Wong ES, Murray BE, Coudron PE, Williams DS, Markowitz SM Infections due to β-lactamase-producing, high-level gentamicin-resistantEnterococcus faecalis. Annals of Internal Medicine 1992, 116: 285–292.PubMedGoogle Scholar
  14. 14.
    Coudron PE, Markowitz SM, Wong ES Isolation of a β-lactamase-producing, aminoglycoside-resistant strain ofEnterococcus facecium. Antimicrobial Agents and Chemotherapy 1992, 36: 1125–1126.PubMedGoogle Scholar
  15. 15.
    Rice LB, Eliopoulos GM, Wennersten C, Goldmann D, Jacoby GA, Moellering RC Chromosomally-mediated β-lactamase production and gentamicin resistance inEnterococcus faecalis. Antimicrobial Agents and Chemotherapy 1991, 35: 272–276.PubMedGoogle Scholar
  16. 16.
    Rice LB, Marshall SH Evidence of incorporation of the chromosomal β-lactamase gene ofEnterococcus faecalis CH 19 into a transposon derived from staphylococci. Antimicrobial Agents and Chemotherapy 1992, 36: 1843–1846.PubMedGoogle Scholar
  17. 17.
    Hindes RG, Willey SH, Eliopoulos GM, Rice LB, Eliopoulos CT, Murray BE, Moellering RC Treatment of experimental endocarditis caused by a β-lactamase producing strain ofEnterococcus faecalis with high-level resistance to gentamicin. Antimicrobial Agents and Chemotherapy 1989, 33: 1019–1022.PubMedGoogle Scholar
  18. 18.
    Ingerman M, Pitsakis PG, Rosenberg A, Hessen MT, Abrutyn E, Murray BE, Levison ME β-lactamase production in experimental endocarditis due to aminoglycoside-resistantStreptococcus faecalis. Journal of Infectious Diseases 1987, 155: 1226–1232.PubMedGoogle Scholar
  19. 19.
    Courvalin P Resistance of enterococci to glycopeptides. Antimicrobial Agents and Chemotherapy 1990, 34: 2291–2296.PubMedGoogle Scholar
  20. 20.
    Livornese LL, Dias S, Samel C, Romanowski B, Taylor S, May P, Pitsakis P, Woods G, Kaye D, Levison ME, Johnson CC Hospital-acquired infection with vancomycin-resistantEnterococcus faecium transmitted by electronic thermometers. Annals of Internal Medicine 1992 117: 112–116.PubMedGoogle Scholar
  21. 21.
    Rubin LG, Tucci V, Cercenado E, Eliopoulos G, Isenberg HD Vancomycin-resistantEnterococcus faecium in hospitalized children. Infection Control and Hospital Epidemiology 1992, 13: 700–705.PubMedGoogle Scholar
  22. 22.
    Arthur M, Molinas C, Depardieu F, Courvalin P Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors inEnterococcus faecium BM4147. Journal of Bacteriology 1993, 175: 117–127.PubMedGoogle Scholar
  23. 23.
    Arthur M, Molinas C, Bugg TDH, Wright GD, Walsh CT, Courvalin P Evidence for in vivo incorporation of D-lactate into peptidoglycan precursors of vancomycin-resistant enterococci. Antimicrobial Agents and Chemotherapy 1992, 36: 867–869.PubMedGoogle Scholar
  24. 24.
    Dutka-Malen S, Molinas C, Arthur M, Courvalin P Sequence of thevanC gene ofEnterococcus gallinarum: BM4174 encoding a D-alanine:D-alanine ligase-related protein necessary for vancomycin resistance. Gene 1992, 112: 53–58.PubMedGoogle Scholar
  25. 25.
    Evers S, Sahm DF, Courvalin P ThevanB gene of vancomycin-resistantEnterococcus faecalis V583 is structurally related to genes encoding D-Ala: D-Ala ligases and glycopeptide-resistance proteins VanA and VanC. Gene 1993, 124: 143–144.PubMedGoogle Scholar
  26. 26.
    Noble WC, Virani Z, Cree RGA Co-transfer of vancomycin and other resistance genes fromEnterococcus faecalis NCTC 12201 toStaphylococcus aureus. FEMS Microbiology Letters 1992, 93: 195–198.Google Scholar
  27. 27.
    Eliopoulos GM Aminoglycoside resistant enterococcal endocarditis. Infectious Disease Clinics of North America 1993, 7: 117–133.PubMedGoogle Scholar
  28. 28.
    Yao JDC, Thauvin-Eliopoulos C, Eliopoulos GM, Moellering RC Efficacy of teicoplanin in two dosage regimens for experimental endocarditis caused by a β-lactamase-producing strain ofEnterococcus faecalis with high-level resistance to gentamicin. Antimicrobial Agents and Chemotherapy 1990, 34: 827–830.PubMedGoogle Scholar
  29. 29.
    Cercenado E, Eliopoulos GM, Wennersten C, Moellering RC Absence of synergistic activity between ampicillin and vancomycin against high-level vancomycin-resistant enterococci. Antimicrobial Agents and Chemotherapy 1992, 36: 2201–2203.PubMedGoogle Scholar
  30. 30.
    Fantin B, Leclercq R, Arthur M, Duval J, Carbon C Influence of low-level resistance to vancomycin on efficacy of teicoplanin and vancomycin for treatment of experimental endocarditis due toEnterococcus faecium. Antimicrobial Agents and Chemotherapy 1991, 35: 1570–1575.PubMedGoogle Scholar
  31. 31.
    Eliopoulos GM, Klimm K, Eliopoulos CT, Ferraro MJ, Moellering RC In vitro activity of CP-99, 219, a new fluoroquinolone, against clinical isolates of gram-positive bacteria. Antimicrobial Agents and Chemotherapy 1993, 37: 366–370.PubMedGoogle Scholar
  32. 32.
    Yuk JH, Dignani C, Harris RL, Bradshaw MW, Williams TW Minocycline as an alternative anti-staphylococcal agent. Reviews of Infectious Diseases 1991, 13: 1023–1024.PubMedGoogle Scholar
  33. 33.
    Collins LA, Malanoski GJ, Eliopoulos GM, Wennersten CB, Ferraro MJ, Moellering RC In vitro activity of RP 59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms. Antimicrobial Agents and Chemotherapy 1993, 37: 598–601.PubMedGoogle Scholar
  34. 34.
    Collins LA, Malanoski GJ, Eliopoulos GM, Wennersten CB, Ferraro MJ, Moellering RC In vitro activity of RP 59500, an injectable streptogramin, against vancomycin-resistant gram-positive organisms. Antimicrobial Agents and Chemotherapy 1993, 37: 598–601.PubMedGoogle Scholar
  35. 35.
    Goldstein BP, Berti M, Ripamonti F, Resconi A, Scotti R, Denaro M In vitro antimicrobial activity of a new antibiotic, MDL 62,879 (GE2270 A). Antimicrobial Agents and Chemotherapy 1993; 37: 741–745.PubMedGoogle Scholar

Copyright information

© Friedr. Vieweg & Sohn Verlagsgesellschaft mbH 1993

Authors and Affiliations

  • G. M. Eliopoulos
    • 1
  1. 1.Department of MedicineDeaconess Hospital, and Harvard Medical SchoolBostonUSA

Personalised recommendations